A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
Dec 16, 2016
0
0
Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.
Oct 26, 2016
0
0
A medical charity scored a small victory Wednesday in its bid to break a US pharma giant's hold on an eye-wateringly expensive Hepatitis C drug when a European body partially revoked the firm's patent.
Oct 5, 2016
0
0
A new analytical test has been launched in the UK that provides sensitive, specific and efficient predictive analysis of a rare form of cancer from a simple urine sample. The ACC steroid analysis service will be marketed ...
Sep 21, 2016
0
4
Horizon Pharma will spend about $800 million to buy Raptor Pharmaceutical and expand its portfolio of rare disease treatments, a growing area of focus for drugmakers.
Sep 12, 2016
0
1
The rising price for EpiPens, a drug delivery system that is crucial for persons experiencing potentially life-threatening allergic reactions, has resulted in outrage. The price increase, from about US$94 for a two-pack of ...
Aug 25, 2016
0
1
A rapid HIV diagnostic kit for developing nations, designed by Cambridge University researcher Helen Lee, won the Popular Prize at the European Inventor Awards on Thursday.
Jun 9, 2016
0
53
A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.
May 23, 2016
1
57
India has granted a patent to US pharmaceutical giant Gilead for a blockbuster Hepatitis C drug, in a U-turn activists said could potentially stop affordable copies reaching millions of people in other countries.
May 10, 2016
0
9
The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.
Mar 25, 2016
0
0
